YHLO has introduced an effective automated CLIA testing for 2019-nCoV IgG/IgM.
CPC is the first company to launch the automated CLIA platform iFlash 1800 in INDIA, facilitating the fastest screening for COVID -19.
It is the first company to develop a CLIA platform for 2019-nCoV IgG and IgM antibodies which can satisfy the clinical needs to detect antibodies for new 2019-nCoV and offer differential diagnosis to doctors.
iFlash 1800 offers comprehensive CLIA solutions up to 180 T/H for detecting 2019-nCoV . Fastest reporting in 27 min.
With a strong R&D team in protein engineering and immunoassay, YHLO achieves stable supply of the raw materials for these CLIA assays.
YHLO has made initial evaluation of these assays, and results showed that these assays have strong anti-interference ability to other respiratory pathogens (e.g. legionella Pneumophila, Mycoplasma Pneumonia, Chlamydia Pneumonia, Q Fever from Rickettsia, Adenovirus, RSV-Respiratory Syncytial Virus, Influenza A, Influenza B, Parainfluenza 1, 2, 3, etc.).
For more information please visit the website of YHLO with the below url: